Cingulate Inc.
CING- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.
Other share classesCINGW
Q4 2022 vs. Q3 2022
How the institutions holding Cingulate Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 8 | 11 | +3 |
| Shares | 265.1K | 112.4K | −152.7K (−57.6%) |
| Value | $283.0K | $112.1K | −$170.9K (−60.4%) |
New holders (5)
Institutions that held Cingulate Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighTower Advisors, LLC | 34,425 | $34.0K | 0.00% |
| Sterneck Capital Management, LLC | 14,144 | $14.1K | 0.01% |
| KC Investment Advisors, LLC | 11,750 | $12.0K | 0.01% |
| Creative Planning | 10,919 | $10.9K | 0.00% |
| Bank of America Corp | 20 | $20 | 0.00% |
Sold out (2)
Institutions that held Cingulate Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eagle Asset Management Inc | 107,527 | $115.0K |
| Ergoteles LLC | 11,399 | $12.0K |